Robert Talbert has authored more than 100 scientific and professional articles and book chapters and is one of the editors of "Pharmacotherapy: A Pathophysiology Approach," now in the fourth edition. His recent contributions include the role of antithrombotic therapy in stroke prevention in nonrheumatic atrial fibrillation as one of the investigators for the Stroke Prevention in Atrial Fibrillation trial. Dr. Talbert has served the American Society of Hospital Pharmacists as Chair of the Special Interest Group in Adult Medicine and as a member of the Commission on Therapeutics. He has served as Chair of the Section of Pharmacy Practice for the American Association of Colleges of Pharmacy. He was Chairman, Research Institute, American College of Clinical Pharmacy August 1993 - August 1994. Dr. Talbert has served as a member of the Specialty Council on Pharmacotherapy of the Board of Pharmaceutical Specialties and Past-President of the American College of Clinical Pharmacy (1992-1993) He has been a member of the Advisory Panel on Cardiovascular and Renal Drugs, The United States Pharmacopeial Convention (1992-1995) and was elected (1986) Fellow of the American College of Clinical Pharmacy (FCCP). Dr. Talbert currently serves on the Board of Directors for Pharmacotherapy Publications, Inc. He is a Board Certified Pharmacotherapy Specialist (Board of Pharmaceutical Specialties). He has been the preceptor for 28 specialty practice residents and five clinical sciences fellows.